Stem Cells for Drug Developers
Conference - Boston, MA, United States
Develop, use and validate your stem cell derived models and assays.
Innovation has been sweeping across the stem cell field over the last 6-12 months. It’s clear that pharma and biotech leaders are making huge progress in differentiation, modeling, screening and predictive toxicology.
The 3rd Stem Cells for Drug Developers meeting will bring together experts from AstraZeneca, Harvard Medical School, Novartis and many others who will help you tackle the key issues to develop, use and validate your stem cell derived models and assays.
So whether you’re developing assays for compound screening or working to improve differentiation protocols, the 3rd Stem Cells for Drug Developers is the place to learn, network and discuss how to achieve these goals.
Stem Cells for Drug Developers
Tue, Mar 19, 2013 - Thu, Mar 21, 2013
Revere Hotel Boston Common, 200 Stuart Street, Boston, MA
02116, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
